Becton Dickinson & Co (BDX)
233.71
+2.77
(+1.20%)
USD |
NYSE |
Jun 28, 16:00
233.66
-0.05
(-0.02%)
After-Hours: 20:00
Becton Dickinson Research and Development Expense (Annual): 1.237B for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.237B |
| September 30, 2022 | 1.256B |
| September 30, 2021 | 1.279B |
| September 30, 2020 | 1.039B |
| September 30, 2019 | 1.062B |
| September 30, 2018 | 1.004B |
| September 30, 2017 | 770.00M |
| September 30, 2016 | 828.00M |
| September 30, 2015 | 632.00M |
| September 30, 2014 | 550.00M |
| September 30, 2013 | 494.00M |
| September 30, 2012 | 472.00M |
| September 30, 2011 | 470.00M |
| September 30, 2010 | 422.77M |
| Date | Value |
|---|---|
| September 30, 2009 | 404.57M |
| September 30, 2008 | 395.63M |
| September 30, 2007 | 360.05M |
| September 30, 2006 | 301.87M |
| September 30, 2005 | 271.63M |
| September 30, 2004 | 235.65M |
| September 30, 2003 | 224.24M |
| September 30, 2002 | 207.20M |
| September 30, 2001 | 211.83M |
| September 30, 2000 | 223.78M |
| September 30, 1999 | 254.00M |
| September 30, 1998 | 217.90M |
| September 30, 1997 | 180.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.039B
Minimum
2020
1.279B
Maximum
2021
1.175B
Average
1.237B
Median
2023
Research and Development Expense (Annual) Benchmarks
| Edwards Lifesciences Corp | 1.072B |
| AngioDynamics Inc | 29.88M |
| Boston Scientific Corp | 1.414B |
| Abbott Laboratories | 2.741B |
| Merit Medical Systems Inc | 84.28M |